Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial

por Mohan, Anant, Tiwari, Pawan, Suri, Tejas Menon, Mittal, Saurabh, Patel, Ankit, Jain, Avinash, Velpandian, Thirumurthy, Das, Ujjalkumar Subhash, Boppana, Tarun Krishna, Pandey, Ravindra Mohan, Shelke, Sushil Suresh, Singh, Angel Rajan, Bhatnagar, Sushma, Masih, Shet, Mahajan, Shelly, Dwivedi, Tanima, Sahoo, Biswajeet, Pandit, Anuja, Bhopale, Shweta, Vig, Saurabh, Gupta, Ritu, Madan, Karan, Hadda, Vijay, Gupta, Nishkarsh, Garg, Rakesh, Meena, Ved Prakash, Guleria, Randeep
Publicado 2021